Mtb72F/AS02
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mtb72F/AS02, covering 2017-05-30 to 2017-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults. [Phase 1]